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Abstract. The health development strategies for 2015-2019 is about improving the availability, affordability, equity and 
quality of pharmaceuticals and medical devices. Since the enactment of national health insurance (JKN) on January 1, 2014, 
the availability of drug at the public health center become a very important aspect in primary health care services. Drug 
logistics management is an important aspect that influences accessibility to health services including the availability of 
essential drugs and vaccines. The aim of this study is to explore the trend of availability indicator drugs and vaccines in 
public health center for the period of 2016-2017 and drug logistics management factors that can affect the availability. The 
study was conducted using secondary data analysis. Data were obtained from data on the availability of indicator drugs and 
vaccines in public health center for the period of 2016-2017. This research is a quantitative study with an analytical 
observational approach. The Vector Auto Regression(VAR) conducted provides forecasting trends in indicator drugs and 
vaccines in public health center close to 80%. The 80% figure shows appropriate availability, but there are a number of 
things that need special attention including planning, procurement, pharmaceutical competency, financing, and 
management information systems. 
Keywords:  availability of indicator drugs and vaccines, public health center, trends 
 
Abstrak. Strategi pembangunan kesehatan tahun 2015-2019 antara lain meningkatkan ketersediaan, keterjangkauan, 
pemerataan, dan kualitas farmasi dan alat kesehatan. Sejak diberlakukannya Jaminan Kesehatan nasional (JKN) pada 1 
Januari 2014, ketersediaan obat di puskesmas merupakan aspek yang sangat penting dalam pelayanan kesehatan di Fasilitas 
Kesehatan Tingkat Pertama (FKTP). Pengelolaan obat di puskesmas haruslah baik dan benar, karena pengelolaan yang baik 
dan benar akan menjamin ketersediaan obat sesuai dengan kebutuhan puskesmas. Penelitian ini ingin melihat  trend 
ketersediaan obat dan vaksin indikator di puskesmas periode tahun 2016-2017. Studi dilakukan dengan menggunakan analisis 
data sekunder. Data didapatkan dari data ketersediaan obat dan vaksin esensial di puskesmas periode tahun 2016-2017. 
Pendekatan Vector Auto Regression (VAR) yang dilakukan memberikan peramalan trend obat dan vaksin indikator di 
puskesmas mendekati angka kurang lebih 80%. Angka tersebut menunjukkan ketersediaan yang sesuai tetapi ada sejumlah 
hal yang perlu mendapat perhatian khusus antara lain peran dan kompetensi tenaga kefarmasian dalam menjamin 
ketersediaan obat, dana kapitasi untuk pembelanjaan obat di puskesmas, perencanaan kebutuhan obat, dan pencatatan dan 
pelaporan di puskesmas. 
 
 Kata kunci: ketersediaan obat dan vaksin indikator, puskesmas, trend 
INTRODUCTION 
Access to medicines explicitly recognized in the 2030 
Agenda for Sustainable Development (SDG). For almost 
all targets of point number 3 of SDGs; good health and 
well-being; increasing access to medicines plays an 
important role in maternal and child health, non-
 
communicable diseases (NCD), malaria, and sexual and 
reproductive health (1).  The World Health Organization 
(WHO) estimated that less than half of the population in 
32 percent of the poorest countries in the world do not 
have regular access to essential medicines. Eighty-one 
percent of countries that have problems with access and 
availability of drugs is a low-income country(2).  
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on the availability of indicator drugs and vaccines, 
published by the Ministry of Health, shows an increase 
in results. In 2016, the percentage of indicator medicines 
and vaccines in public health centers was 81.57%; 
meanwhile, in 2017, it was increased to become 89.29%. 
 
Drug logistics management is an important aspect that 
influences access to health services, including the 
availability of essential drugs and vaccines. If one 
component of the drug logistics management cycle is not 
optimal, it can lead to a drug and vaccines stock out in 
health care facilities that affect health services to the 
community. The aims of this study to explore the trend 
of availability indicator drugs and vaccines in public 
health centers for the period of 2016-2017. 
 
METHODS 
 
This research is a quantitative study conducted using 
secondary data analysis. We use the data on the 
availability of indicator drugs and vaccines in public 
health centers for the period of 2016-2017. The basis of 
selecting indicator drug items are drugs supporting 
maternal health programs, child health, prevention of 
diseases, as well as essential health care drugs and 
contained in the National Formulary(8). Availability of 
indicator drug and vaccines were checked from public 
health centers throughout Indonesia. Data were analyzed 
using an official data processing tool. 
Table 1. List of Indicator Drugs and Vaccines in the Public Health 
Center. 
NO MEDICINE NAME UNIT 
1 Albendazol tab Tablet 
2 Amoxicillin 500 mg tab Tablet 
3 Amoxicillin syrup  Bottle 
4 Deksametason tab Tablet 
5 Diazepam injection 5 
mg/mL 
Ampoule 
6 Epinefrin (Adrenalin) 
injection 0,1% (as HCL) 
Ampoule 
7 Fitomenadion (Vitamin 
K) injection 
Ampoule 
8 Furosemid tablet 40 
mg/Hidroklorotiazid 
(HCT) 
Tablet 
9 Oralit Bag 
10 Glibenklamid/Metformin Tablet 
11 Kaptopril tab Tablet 
12 Magnesium Sulfat 
injection 20 % 
Vial 
In 2008, research conducted by Cameron in 36 
developing countries noted that the availability of 
generic drugs ranged from 29-54% in the public sector, 
where Africa recorded as the lowest and United States as 
the highest. The availability of 15 generic drug items 
ranges from 10% in Yemen to 79% in Mongolia (3). All 
countries in Southeast Asia were committed to providing 
essential medicines for those who need them. 
Procurement and supply chains are weak in some 
countries, and many drug sales are not regulated(4). 
Vaccination has an unrivaled impact on global health, 
and vaccines have the most significant potential for 
further improvement in health in the poorest countries of 
the world. In addition to the direct benefit of vaccines in 
preventing disease and death, there is growing evidence 
that their widespread implementation leads to much-
needed economic development(5). 
At the first meeting in 1977, the WHO Expert Committee 
on Selection of Essential Drugs described essential 
medicines as medicines that were "very important and 
basic, very necessary for the health needs of the 
population." While at a meeting held in 1999, the 
Committee stated that "Essential medicines are those that 
meet the health care needs of the majority of the 
population; therefore they must be available at all times 
in sufficient quantities and in appropriate dosage forms 
and at prices affordable to individuals and the 
community "(6). Access to health services, including 
essential medicines, is a fundamental human right. 
Access to health services is a construct covering different 
dimensions, which are availability, affordability, 
accessibility, and acceptance (2). 
 
Figure 1. Access to health care 
 
The percentage of the public health center with the 
availability of essential medicines and vaccines is an 
indicator of the Ministry of Health's Strategic Plan for 
2015-2019 related to access, independence and quality 
of pharmaceutical preparations and medical devices(7). 
The 2019 target is to get 90% of the public health center 
has the availability of indicator drugs and vaccines. Data 
62 
   
 
 
 
 
JOURNAL OF INDONESIAN HEALTH POLICY AND ADMINISTRATION  
 
 
Juli 2019, Vol. 4, No. 2, hal 61-66 
 
13 Metilergometrin Maleat 
inj  0,200 mg-1 ml 
Ampoule 
14 Anti tuberculosis drug 
(Adult) 
Package 
15 Oksitosin injection Ampoule 
 
16 Parasetamol 500 mg tab Tablet 
17 Iron and folic acid Tablet Tablet 
18 Vaccine BCG Vial 
19 Vaccine DPT/ DPT-HB/ 
DPT-HB-Hib 
Vial 
20 Vaksin Td Vial 
 
 
RESEARCH RESULTS AND DISSCUSION  
 
 
Figure 2. Data on Indicator Drug and Vaccine Availability in 
the Public Health Center for the 2016-2017 Period 
 
The figure shows a tendency to increase the percentage 
of the national number. In January 2017, the availability 
of indicator drugs and vaccines reached the lowest point 
of 74.7%, while on December 2017 reached the highest 
point, which was 89.2%. On average, it can be seen that 
the availability rate reaches 80%.  
Data analysis on the trend of the availability of drugs and 
vaccines is using the Vector Auto Regression (VAR) 
method approach as the method that does not distinguish 
the endogenous and exogenous variables. Endogenous 
variables are variables whose values are specified in the 
model. Although it is not the same, this endogenous 
variable is similar to the dependent variable in 
regression, where the value can be determined if the 
value of the independent variable has been determined 
first. While exogenous variables are variables that are 
determined outside the model or often said this variable 
is similar to the independent variable. 
Table 2. Application of Models for Forecasting Drug and Vaccines 
Availability at the public health center 
Observation 
(Month) 
Predicted 
Y Residuals 
1 83.17 -0.47 
2 81.70 0.20 
3 81.06 -0.66 
4 79.82 -0.32 
5 79.39 -1.14 
6 78.85 1.50 
7 81.52 -0.05 
8 83.03 -0.76 
9 82.82 0.16 
10 82.98 0.80 
11 83.38 0.22 
12 82.80 0.19 
13 81.84 0.31 
14 81.11 0.11 
15 80.51 -0.08 
16 80.15 -0.14 
17 80.21 -0.65 
18 80.14 0.67 
  
The VAR approach forecasts the trends in indicator 
drugs and vaccines in public health centers close to 
approximately 80%. Many benefits occur by 
establishing a list of essential medicines in a country. For 
health effects, essential medicines can save lives and 
reduce suffering, especially for the poor. For economic 
impacts by focusing on essential medicines, rational 
drug selection, good procurement practices, reliable 
quality assurance, and efficient distribution systems, the 
best health services for public drug expenditure can be 
guaranteed(9). Essential drug policies can help countries 
to rationalize the purchase and distribution of drugs, 
thereby reducing costs for public and private health 
systems, increasing the accessibility of medicines and 
increasing the rational use of drugs (10). 
 
The reformation of the health financing system in 
Indonesia started on January 1, 2014. The NHI program 
aims to guarantee the benefits of health care and 
financial protection for participants. Things covered by 
NHI are promotive, preventive, curative, and 
rehabilitative benefits, including medical services and 
medical materials consumable per medical needs (11). 
The supply of drugs in NHI has been regulated in the 
National Formulary, which is a list of medicines 
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  compiled by the National Committee for National 
Formulary.  
 
The trend results in the availability of drugs and vaccines 
in health centers that can be used for predicting data on 
the availability of drugs and vaccines for the next 18 
months, shows the average availability of drugs and 
vaccines were around 80% for 20 indicator drug items 
monitored by the Ministry of Health. Although national 
data show a high result, some things still need special 
attention, especially in drug logistics management. Drug 
logistics management plays a vital role in ensuring 
access to health services, including the availability of 
drugs. Drug logistics management aims at the 
availability of good quality drugs, evenly distributed, 
types, and quantities by the essential health care needs of 
the community in the health care unit. 
 
Generally, the cycle of drug logistics management 
consists of planning, procurement, storage, distribution, 
and use (12). Meanwhile, according to Managing Access 
to Medicines and Health Technologies, drug 
management involves four essential functions: selection, 
procurement, distribution, and use with drug 
management as core supporters including organization, 
sustainable financing, information management, and 
human resources (2).  
 
The needs planning process done by the public health 
center refers to the 2002 Guidelines for Public Drug 
Management and Health Supplies. There are two types 
of methods commonly used, which are the consumption 
method and morbidity method. The consumption 
method is based on the analysis of the previous year's 
drug consumption data, while the morbidity method is a 
method of calculating drug needs based on the 
epidemiology. Most public health center only calculates 
drug needs based on consumption methods even though 
the ideal in quantifying drug needs is combining 
consumption patterns and disease patterns. If only using 
consumption patterns, it is likely that if the previous use 
of the drug is already irrational, it will continue to be 
irrational. If using disease patterns alone, there are 
difficulties in estimating because the prevalence of the 
disease continually changes over time (13). 
 
In the era of NHI, there are capitation funds that can be 
used to purchase drugs directly by the public health 
center. As stipulated in article 3 of the Regulation of the 
Minister of Health of the Republic of Indonesia number 
21 of 2016, capitation funds received by primary health 
care facilities from the Health Social Security 
Organizing Agency are used entirely for payment and 
support for operational costs of health services. These 
operational costs, as intended, is used for the cost of 
medicines, medical devices, and medical materials 
consumables and other operational costs of health 
services. The utilization of medicines at the public health 
center is still not optimal due to constraints in the 
procurement process (14). 
 
The process of procuring medicines based on electronic 
catalogs has established since 2014. The regulation of 
procurement of drugs based on electronic catalogs aims 
to ensure transparency, effectiveness, and efficiency of 
e-purchasing planning and drug procurement processes 
based on electronic catalogs done by government 
institutions and private institutions. However, there are 
still obstacles related to the procurement of medicines in 
the district/city, causing a stock-out drug and vaccines 
at the public health center(15). 
 
The efforts to increase the competence of 
pharmaceutical workers also have an essential role to 
play through sustainable professional development 
through the process of education and training. 
Regulation of the Minister of Health number 74 of 2016 
concerning pharmaceutical service standards at the 
public health center, states that pharmacy personnel at 
the public health center must always improve their 
knowledge, skills, and behavior in order to maintain and 
improve their competence(16). If competence is 
inadequate, it can likely affect the process of managing 
drugs and impact the availability of drugs (17). 
 
Recording and reporting at the public health center, 
commonly known as the Use Report and Drug Request 
Sheet, is sent to the district/city pharmacy installation as 
a routine report. Management of receipt and distribution 
data is an essential key to producing the report. Data 
management does not work well, especially at the public 
health center and district / municipal pharmacy level 
because of limited human resources and continuous 
distribution service activities. Manually compiling data 
with limited resources makes it challenging to produce 
full and timely reports (18). 
 
CONCLUSION  
 
To establish access, independence, and quality of 
pharmaceutical preparations and medical devices 
requires high commitment. Strategies that need to be 
planned include ensuring the availability of essential 
medicines in health care facilities, especially in the 
public health center by conducting drug management 
according to standards at provincial, district/city 
pharmacy installations. From the results of data on the 
availability of indicator drugs and vaccines in public 
health centers in 2016-2017, there is a tendency for the 
percentage of national figures to increase. Data analysis 
on the availability trends of indicator drugs and vaccines 
in the public health center shows the results of the VAR 
approach, giving forecasting trends in indicator drugs 
and vaccines in public health centers close to 
approximately 80%. However, since the enactment of 
the NHI era, public demand for medicinal needs has 
increased so that the availability of medicines in public 
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health center needs to be maintained by paying particular 
attention to the factors of drug logistics management are 
planning, procurement, pharmaceutical competency, 
drug financing, and management information. 
 
RECOMMENDATIONS  
  
Based on the results of the study, although the 
availability trend rate is around 80%, it is recommended 
that the drug logistics management cycle must be run 
well and optimally. Drugs planning, other than the 
consumption method, also considers the epidemiology in 
the district/city. Capitation funds for drug spending at the 
public health center can be used optimally to ensure the 
availability of medicines. Drug procurement using e-
purchasing to fulfill the drug needs for the NHI program 
can be done well even though the budget is limited. 
Continuous training needs to be prepared on pharmacy 
staff at the health center and advocacy to the local 
government for the placement of pharmaceutical 
personnel in the public health center. Moreover, the use 
of information and communication technology that has 
some potential can better accommodate recording and 
reporting needs. 
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